| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Epidemiology, Joseph L. Mailman School of Public Health [M. B. T., A. I. N., J. S. J.], and Herbert Irving Comprehensive Cancer Center [M. B. T., A. I. N., J. S. J.] and Department of Medicine [A. I. N.], College of Physicians and Surgeons, Columbia University, New York, New York 10032; South Carolina Cancer Center, University of South Carolina, Columbia, South Carolina 29203 [R. M. B.]; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7080 [R. S. S.]; Department of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California 90033 [R. W. H.]; Department of Pathology and Laboratory Medicine, College of Medicine, University of Cincinnati, Cincinnati, Ohio 45267-0529 [C. F-P.]; and Cancer Prevention Research, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 [J. D. P.]
Although most colorectal cancers arise from adenomatous polyps, most adenomas do not progress to invasive cancer. Understanding the epidemiology of advanced adenomas, specifically those with severe dysplasia, carcinoma in situ, or intramucosal carcinoma, is crucial to uncovering why some adenomas progress and some do not. Using data from four colonoscopy-based adenoma case-control studies, we compared two case groups: subjects with advanced adenomas (those with severe dysplasia, carcinoma in situ, or intramucosal carcinoma; n = 119) and subjects with nonadvanced adenomas (those with none, mild, or moderate dysplasia; n = 441) to a polyp-free control group (n = 1866) in regard to frequently studied risk factors for colorectal neoplasia. All of the cases were newly diagnosed and had no prior history of adenomas. We used an unordered polytomous logistic model to calculate multivariate odds ratios for advanced and nonadvanced adenoma cases relative to polyp-free controls. Among women, ever use of hormone replacement therapy was more strongly associated with reduced risk of advanced adenomas relative to polyp-free controls [odds ratio (OR), 0.4; 95% confidence interval (CI), 0.2–0.9] than with reduced risk of nonadvanced adenomas (OR, 0.7; 95% CI, 0.4–1.0). Among men, increased physical activity (
2 h/week) was more strongly associated with reduced risk for advanced adenomas (OR, 0.4; 95% CI, 0.2–1.0) than with reduced risk for nonadvanced adenomas (OR, 0.8; 95% CI, 0.5–1.2). Apart from these differences, most other risk factors, including body size and cigarette smoking were similar in their association with advanced and nonadvanced adenomas, suggesting that many risk factors for colorectal neoplasia may be important to adenoma formation but not to dysplasia per se.
This article has been cited by other articles:
|
|
 |
|
  M. J. Shrubsole, H. Wu, R. M. Ness, Y. Shyr, W. E. Smalley, and W. Zheng Alcohol Drinking, Cigarette Smoking, and Risk of Colorectal Adenomatous and Hyperplastic Polyps Am. J. Epidemiol., May 1, 2008; 167(9): 1050 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Campbell, M. Cotterchio, E. Dicks, P. Parfrey, S. Gallinger, and J. R. McLaughlin Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1735 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Newcomb, Y. Zheng, V. M. Chia, L. M. Morimoto, V. P. Doria-Rose, A. Templeton, S. N. Thibodeau, and J. D. Potter Estrogen Plus Progestin Use, Microsatellite Instability, and the Risk of Colorectal Cancer in Women Cancer Res., August 1, 2007; 67(15): 7534 - 7539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Terry, Y. Wei, and D. Esserman Terry et al. Respond to "Antecedents of Obesity" Am. J. Epidemiol., July 1, 2007; 166(1): 17 - 18. [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. S. Wong, L. Yu, E. K. Y. Lam, E. K. K. Tai, W. K. K. Wu, and C.-H. Cho Nicotine Promotes Colon Tumor Growth and Angiogenesis through {beta}-Adrenergic Activation Toxicol. Sci., June 1, 2007; 97(2): 279 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Sedjo, T. Byers, T. R. Levin, S. M. Haffner, M. F. Saad, J. A. Tooze, and R. B. D'Agostino Jr. Change in Body Size and the Risk of Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 526 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Grau, J. A. Baron, R. S. Sandler, K. Wallace, R. W. Haile, T. R. Church, G. J. Beck, R. W. Summers, E. L. Barry, B. F. Cole, et al. Prolonged Effect of Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial J Natl Cancer Inst, January 17, 2007; 99(2): 129 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Stern, K. D. Siegmund, D. V. Conti, R. Corral, and R. W. Haile XRCC1, XRCC3, and XPD Polymorphisms as Modifiers of the Effect of Smoking and Alcohol on Colorectal Adenoma Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Rosenberg, D. Boggs, L. A. Wise, J. R. Palmer, M. H. Roltsch, K. H. Makambi, and L. L. Adams-Campbell A Follow-up Study of Physical Activity and Incidence of Colorectal Polyps in African-American Women. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1438 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Burling, S. Halligan, S. Taylor, D. J. Brennand, D. G. Altman, P. Bassett, W. Atkin, and C. I. Bartram Polyp measurement using CT colonography: agreement with colonoscopy and effect of viewing conditions on interobserver and intraobserver agreement. Am. J. Roentgenol., June 1, 2006; 186(6): 1597 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Kroenke, G. G. Bennett, C. Fuchs, E. Giovannucci, I. Kawachi, E. Schernhammer, M. D. Holmes, and L. D. Kubzansky Depressive Symptoms and Prospective Incidence of Colorectal Cancer in Women Am. J. Epidemiol., November 1, 2005; 162(9): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Grau, J. A. Baron, E. L. Barry, R. S. Sandler, R. W. Haile, J. S. Mandel, and B. F. Cole Interaction of Calcium Supplementation and Nonsteroidal Anti-inflammatory Drugs and the Risk of Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2353 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wallace, J. A. Baron, M. R. Karagas, B. F. Cole, T. Byers, M. A. Beach, L. H. Pearson, C. A. Burke, W. B. Silverman, and R. S. Sandler The Association of Physical Activity and Body Mass Index with the Risk of Large Bowel Polyps Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2082 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. K.K. Wu, H. P.S. Wong, S. W. Luo, K. Chan, F. Y. Huang, M. K.C. Hui, E. K.Y. Lam, V. Y. Shin, Y. N. Ye, Y. H. Yang, et al. 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone from Cigarette Smoke Stimulates Colon Cancer Growth via {beta}-Adrenoceptors Cancer Res., June 15, 2005; 65(12): 5272 - 5277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. J. Tranah, E. Giovannucci, J. Ma, C. Fuchs, S. E. Hankinson, and D. J. Hunter Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study Carcinogenesis, July 1, 2004; 25(7): 1211 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Reid, J. R. Marshall, D. Roe, M. Lebowitz, D. Alberts, A. K. Battacharyya, and M. E. Martinez Smoking Exposure as a Risk Factor for Prevalent and Recurrent Colorectal Adenomas Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1006 - 1011. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
